AYTU BIOPHARMA, INC Accrued Liabilities, Current
AYTU BIOPHARMA, INC (AYTU) had Accrued Liabilities, Current of $35.20 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-09-22
- 2026-06-30: Accrued Liabilities, Current $35.20M.
- 2026-03-31: Accrued Liabilities, Current $34.27M.
- 2025-12-31: Accrued Liabilities, Current $40.16M.
- 2025-09-30: Accrued Liabilities, Current $36.70M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $35.20M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $34.27M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $40.16M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $36.70M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $38.16M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $41.73M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $39.37M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $33.72M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $38.14M 10-K · filed 2025-09-23 | $38.57M 10-K · filed 2024-09-26 |
| 2024-03-31 | $44.09M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $43.41M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $40.73M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $46.80M 10-K · filed 2024-09-26 | |
| 2023-03-31 | $49.59M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $41.22M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $41.43M 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | $44.19M 10-K · filed 2023-10-12 | |
| 2022-03-31 | $53.47M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $50.69M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $54.38M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $57.23M 10-K · filed 2022-09-27 | $51.30M 10-K · filed 2021-09-28 |
| 2021-03-31 | $43.18M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $8.88M 10-Q · filed 2021-02-11 | |
| 2020-12-30 | $8.88M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $8.69M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $8.83M 10-K · filed 2021-09-28 | $7.85M 10-K · filed 2020-10-06 |
| 2020-03-31 | $9.83M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.11M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $1.15M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.31M 10-K · filed 2020-10-06 | $1.15M 10-K · filed 2019-09-26 |
| 2019-03-31 | $772.14K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $932.69K 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $428.85K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $185.88K 10-K · filed 2019-09-26 | |
| 2018-03-31 | $211.41K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $257.63K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $903.39K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $782.54K 10-K · filed 2018-09-06 | |
| 2017-03-31 | $1.05M 10-Q · filed 2017-05-11 | |
| 2016-06-30 | $1.20M 10-K · filed 2017-08-31 | |
| 2015-02-28 | $1.60K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $1.60K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $1.60K 10-Q · filed 2015-04-15 | |
| 2014-05-31 | $800.00 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $12.80K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $800.00 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $800.00 10-Q · filed 2014-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |